FOLH1 and prostate cancer: With interest, we read the article by Rosenzweig et al. on the comparison of prostate cancer (PCa) patients with a low and high prostate-specific membrane antigen (PSMA) expression on positron emission tomography/computed tomography (PET/CT) [1].